Evonik Degussa Corporation’s Exclusive Synthesis & Catalysts business unit focuses its extensive technological and catalysis expertise on delivering solutions to customers through custom manufacturing of chemical catalysts, advanced pharmaceutical intermediates and active pharmaceutical ingredients. With a global network of sites, the business unit offers seamless service from small-scale synthesis development to commercial-scale production. Recognized for its catalytic system solutions, the Catalysts business line offers a wide assortment of specialized homogeneous and heterogeneous catalysts, as well as all-round service in the life sciences, fine chemicals, industrial chemicals, intermediates, and polymer industries. Evonik Degussa Corporation's Building Blocks business unit produces and/or markets high quality synthetic intermediates. Its activities are based on the continual development and refinement of a broad range of products, using its technological expertise, back integration of most essential raw materials, and above all its market knowledge. Building Blocks' intermediates include alkoxides, alkyl chlorides, pyrimidines, cyanuric chloride, cyanoacetates, malonates, ortho esters, phenolic antioxidants, and triacetoneamine derivatives, as well as speciality building blocks.
